0Y6X Stock Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 0Y6X from our risk checks.
Medtronic plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$83.54 |
52 Week High | US$91.91 |
52 Week Low | US$68.87 |
Beta | 0.77 |
1 Month Change | -0.13% |
3 Month Change | 0.98% |
1 Year Change | 5.88% |
3 Year Change | -29.72% |
5 Year Change | -6.09% |
Change since IPO | 1.41% |
Recent News & Updates
Recent updates
Shareholder Returns
0Y6X | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | -0.4% | -1.1% | 2.2% |
1Y | 5.9% | 2.3% | 3.7% |
Return vs Industry: 0Y6X exceeded the UK Medical Equipment industry which returned 2.3% over the past year.
Return vs Market: 0Y6X exceeded the UK Market which returned 3.7% over the past year.
Price Volatility
0Y6X volatility | |
---|---|
0Y6X Average Weekly Movement | 1.9% |
Medical Equipment Industry Average Movement | 7.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0Y6X has not had significant price volatility in the past 3 months.
Volatility Over Time: 0Y6X's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1949 | 95,000 | Geoff Martha | https://www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.
Medtronic plc Fundamentals Summary
0Y6X fundamental statistics | |
---|---|
Market cap | US$111.14b |
Earnings (TTM) | US$4.20b |
Revenue (TTM) | US$32.32b |
26.5x
P/E Ratio3.4x
P/S RatioIs 0Y6X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0Y6X income statement (TTM) | |
---|---|
Revenue | US$32.32b |
Cost of Revenue | US$11.08b |
Gross Profit | US$21.24b |
Other Expenses | US$17.04b |
Earnings | US$4.20b |
Last Reported Earnings
Jan 26, 2024
Next Earnings Date
May 23, 2024
Earnings per share (EPS) | 3.16 |
Gross Margin | 65.72% |
Net Profit Margin | 13.00% |
Debt/Equity Ratio | 48.3% |
How did 0Y6X perform over the long term?
See historical performance and comparison